| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $5.0M | $4.2M | $8.8M |
| YoY Revenue Growth % | +19.0% | -51.6% | — |
| Gross Profit | $1.8M | $2.7M | — |
| Gross Margin % | 35.9% | 63.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$17.2M | -$7.8M | $289.0K |
| Operating Margin % | -80.0% | -80.0% | 3.3% |
| Net Income (GAAP) | -$49.1M | -$1.4M | -$339.0K |
| EBITDA (Normalized) | -$13.1M | -$7.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$8.9M | -$4.9M | -$2.9M |
| Capital Expenditures (CapEx) | $5.1M | $844.0K | — |
| Free Cash Flow (FCF) | -$14.1M | -$5.8M | -$2.9M |
| FCF Margin % | -80.0% | -80.0% | -33.1% |
| Return on Invested Capital (ROIC %) | -6.7% | -45.0% | — |
| Cash & Short-Term Equivalents | $138.0M | $19.8M | — |
| Total Debt (Short + Long Term) | $112.0K | — | — |
| Total Stockholders' Equity | $339.7M | $29.9M | — |